Oncorena AB
556864-0808ActiveDeveloping a breakthrough treatment for metastatic renal cancer using orellanine.
Pharmaceutical / Biotech Companyoncorena.com
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2011
- Founded
Key Decision Makers
Börje Haraldsson
CEO
@oncorena.com+46702XXXXXX
Susanna Dahlgren
Chief Operating Officer
@oncorena.com
Åsa Holmgren
Head of Regulatory Affairs
@oncorena.com
Description
Oncorena AB is a Swedish pharmaceutical company founded in 2011, currently headquartered in Lund. Their primary mission is to transform a natural substance into a breakthrough treatment for patients with metastatic renal cancer. The company is developing ONC175, the synthetically produced active ing...